A Perioperative Blood Conservation Protocol to Achieve Successful Bloodless Heart Transplantation

Heart transplantation (HT) is the definitive therapy for end-stage heart failure. Patients unwilling to receive blood product transfusions are often considered ineligible for HT due to the significant perioperative bleeding risk. "Bloodless" HT-that is, without use of blood product transfusions-provides the opportunity to extend this critical intervention to such patients. Here we describe our center's peri-transplant blood conservation protocol that supported successful bloodless HT in two patients unwilling to receive blood product transfusions. One of these patients represents the first described case of temporary mechanical circulatory support as a bridge to bloodless HT, which is of particular importance given the increasing use of such support before HT more broadly. Clinical management decisions and interventions that decreased blood loss, minimized bleeding risk, and stimulated erythropoiesis are highlighted. Utilization of similar strategies may allow for expansion of bloodless HT to centers that have previously not offered this therapy.

Authors

Institutions

Publication Details

Journal
ASAIO Journal
Published
2025-12-09
DOI
https://doi.org/10.1097/mat.0000000000002626
Primary Topic
Transplantation: Methods and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Perioperative Blood Conservation Protocol to Achieve Successful Bloodless Heart Transplantation

David A. D’Alessandro, Kemar Brown, Van‐Khue Ton, Christopher Newton‐Cheh et al.
ASAIO Journal
Transplantation: Methods and Outcomes
article

A Perioperative Blood Conservation Protocol to Achieve Successful Bloodless Heart Transplantation

David A. D’Alessandro, Kemar Brown, Van‐Khue Ton, Christopher Newton‐Cheh, Andrew S. Oseran, Tanvir Kahlon, Jordan D. Secor, Jerome Crowley, Ioannis Mastoris, Antonia Kreso, Gregory D. Lewis, William D. Carlson, Guilherme Nasi, Meaghan Doucette, Erin Coglianese, Charounipha Soydara, Kristian Bakken, Megan Kramer, Daniel A. Zlotoff, Eriberto Michel, R. M. A. McClelland, Frederick Lang, Bin Yang, Lana Tsao, Esther Shao, Julia Allen, Vlada Usherenko
article en

Abstract

Heart transplantation (HT) is the definitive therapy for end-stage heart failure. Patients unwilling to receive blood product transfusions are often considered ineligible for HT due to the significant perioperative bleeding risk. "Bloodless" HT-that is, without use of blood product transfusions-provides the opportunity to extend this critical intervention to such patients. Here we describe our center's peri-transplant blood conservation protocol that supported successful bloodless HT in two patients unwilling to receive blood product transfusions. One of these patients represents the first described case of temporary mechanical circulatory support as a bridge to bloodless HT, which is of particular importance given the increasing use of such support before HT more broadly. Clinical management decisions and interventions that decreased blood loss, minimized bleeding risk, and stimulated erythropoiesis are highlighted. Utilization of similar strategies may allow for expansion of bloodless HT to centers that have previously not offered this therapy.

ASAIO Journal
Massachusetts General Hospital (US)
Openalex Percentile: Top 41%
Transplantation: Methods and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.